A pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis
Latest Information Update: 02 Aug 2024
At a glance
- Drugs Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Umeclidinium/vilanterol (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- Acronyms DIBS
Most Recent Events
- 02 Jun 2021 Status changed from not yet recruiting to recruiting.
- 12 Feb 2021 Planned start date changed from 1 Feb 2020 to 1 Jun 2021.
- 11 Jun 2020 Planned End Date changed from 1 Aug 2023 to 31 Jul 2024.